FIELD: medicine, therapy. SUBSTANCE: curative composition has N-acetylcysteine, artificial sweetening substance, for example, saccharin, cyclamates or their mixtures, thickening agent (carboxymethylcellulose sodium or hydroxypropylmethylcellulose or their mixture). Composition can contain aromatic substance and preserving agent also. Composition must has pH 5.0-8.0. Composition can be used at catarrhal diseases. EFFECT: improved properties of composition. 7 cl
| Title | Year | Author | Number |
|---|---|---|---|
| SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING (S)-2-(4-ISO-BUTYLPHENYL)-PROPIONIC ACID AS ACTIVE COMPONENT AND MICROCRYSTALLINE CELLULOSE AND COLLOIDAL SILICON OXIDE | 1995 |
|
RU2168980C2 |
| 2-AMINO-1,2,3,4-TETRAHYDRONAPHTALENE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, AND COMPOSITION HAVING CARDIOVASCULAR ACTIVITY | 1993 |
|
RU2120435C1 |
| ORAL SUSPENSION CONTAINING HIGH DOSE OF MOFETIL MYCOPHENOLATE | 1994 |
|
RU2150942C1 |
| CEFUROXIME AXETYL-CONTAINING PHARMACEUTICAL COMPOSITION WITH MASKED BITTER TASTE | 2002 |
|
RU2241460C2 |
| PHYSICALLY AND CHEMICALLY STABLE ORAL SUSPENSION OF GIVINOSTAT | 2016 |
|
RU2721396C2 |
| SABELUZOL AQUEOUS SUSPENSION FOR ORAL USE AND METHOD OF ITS PREPARING | 1995 |
|
RU2141821C1 |
| 9-O-OXIME DERIVATIVES OF ERYTHTROMYCIN A AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1995 |
|
RU2152951C1 |
| 2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALENE DERIVATIVES HAVING ACTIVITY WITH RESPECT TO CARDIOVASCULAR SYSTEM, AND PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2149158C1 |
| VITAMINS-CONTAINING SYRUP FOR NON-ADULTS | 2004 |
|
RU2369271C2 |
| SOLID MEDICINAL FORM FOR ORAL ADMINISTRATION OF PHARMACEUTICALLY ACTIVE SUBSTANCES SHOWING UNFAVORABLE ORGANOLEPTIC PROPERTIES | 1991 |
|
RU2085190C1 |
